A cell culture living attenuated feline panleukopenia vaccine was prepared on VERO cell culture. The results obtained demonstrated the safety and effectiveness of such vaccine. Safety was determined by the inability of the vaccine to cause disease, and efficacy was determined by the ability of the product to induce antibody production in susceptible cats and by the immunity challenge. Among the use of two different routes of vaccination subcutaneously or intramuscularly, it was found that there was no significant difference in antibody titre induced in cats vaccinated using the two routes.
ATTYAT, M., GUIRGUIS, W. I., & KHODEIR, M. (1998). PREPARATION OF SPECIFIC FELINE PANLEUKOPENTA VACCINE. Veterinary Medical Journal (Giza), 46(4), 737-742. doi: 10.21608/vmjg.1998.377368
MLA
M.K. ATTYAT; W. I. GUIRGUIS; M.H. KHODEIR. "PREPARATION OF SPECIFIC FELINE PANLEUKOPENTA VACCINE", Veterinary Medical Journal (Giza), 46, 4, 1998, 737-742. doi: 10.21608/vmjg.1998.377368
HARVARD
ATTYAT, M., GUIRGUIS, W. I., KHODEIR, M. (1998). 'PREPARATION OF SPECIFIC FELINE PANLEUKOPENTA VACCINE', Veterinary Medical Journal (Giza), 46(4), pp. 737-742. doi: 10.21608/vmjg.1998.377368
VANCOUVER
ATTYAT, M., GUIRGUIS, W. I., KHODEIR, M. PREPARATION OF SPECIFIC FELINE PANLEUKOPENTA VACCINE. Veterinary Medical Journal (Giza), 1998; 46(4): 737-742. doi: 10.21608/vmjg.1998.377368
', './data/vmjg/coversheet/cover_en.jpg'))
View on SCiNiTO